Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting β2-agonist in persistent asthma

被引:0
|
作者
Hoshino, Makoto [1 ]
Akitsu, Kenta [2 ]
Ohtawa, Junichi [2 ]
机构
[1] Int Univ Hlth & Welf, Atami Hosp, Dept Internal Med, Div Clin Allergy, Atami, Japan
[2] Int Univ Hlth & Welf, Atami Hosp, Dept Radiol, Atami, Japan
关键词
D O I
10.1183/13993003.congress-2018.PA5006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA5006
引用
收藏
页数:2
相关论文
共 50 条
  • [31] The Impact Of Tiotropium On Mortality When Added To Inhaled Corticosteroids And Long-Acting Beta Agonist Therapy In COPD
    Short, P. M.
    Anderson, W. J.
    Williamson, P. A.
    Lipworth, S. I. W.
    Elder, D. H. J.
    Schembri, S.
    Lipworth, B. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [32] Step-down therapy for asthma with inhaled steroids alone or in combination with a long acting β2-agonist
    Fowler, S
    Currie, GP
    Lipworth, BJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S245 - S245
  • [33] The Impact of Tiotropium on Mortality and Exacerbations When Added to Inhaled Corticosteroids and Long-Acting β-Agonist Therapy in COPD
    Short, Philip M.
    Williamson, Peter A.
    Elder, Douglas K. J.
    Lipworth, Samuel I. W.
    Schembri, Stuart
    Lipworth, Brian J.
    CHEST, 2012, 141 (01) : 81 - 86
  • [34] Combination therapy with inhaled long-acting β2-agonists and inhaled corticosteroids:: A paradigm shift in asthma management
    Stoloff, S
    Poinsett-Holmes, K
    Dorinsky, PM
    PHARMACOTHERAPY, 2002, 22 (02): : 212 - 226
  • [35] SAFETY AND TOLERABILITY OF MOMETASONE FUROATE/FORMOTEROL FOR PERSISTENT ASTHMA SUBJECTS WHO PREVIOUSLY WERE TREATED WITH MEDIUM-DOSE INHALED CORTICOSTEROIDS (ALONE OR WITH A LONG-ACTING β2-AGONIST)
    Nathan, R.
    Pearlman, D.
    Nolte, H.
    Nayak, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A58 - A58
  • [36] Comparing Usability of NEXThaler® with Other Inhaled Corticosteroid/Long-Acting β2-Agonist Fixed Combination Dry Powder Inhalers in Asthma Patients
    Voshaar, Thomas
    Spinola, Monica
    Linnane, Patrick
    Campanini, Alice
    Lock, Daniel
    Lafratta, Anthony
    Scuri, Mario
    Ronca, Barbara
    Melani, Andrea S.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (05) : 363 - 370
  • [37] Extrafine HFA-Beclomethasone- Formoterol vs Nonextrafine Combination of an Inhaled Corticosteroid and a Long Acting β2-Agonist in Patients with Persistent Asthma
    Yang, D.
    Liu, T.
    Yang, L.
    Huang, T.
    Guo, X.
    Wang, X.
    Liu, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [38] Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review
    Wechsler, Michael E.
    Oppenheimer, John J.
    JOURNAL OF ASTHMA, 2023, 60 (09) : 1633 - 1645
  • [39] Real-world effects of two inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
    Yatera, Kazuhiro
    Yamasaki, Kei
    Nishida, Chinatsu
    Noguchi, Shingo
    Oda, Keishi
    Akata, Kentarou
    Nagata, Shuya
    Kawanami, Yukiko
    Kawanami, Toshinori
    Ishimoto, Hiroshi
    Mukae, Hiroshi
    JOURNAL OF ASTHMA, 2014, 51 (07) : 762 - 768
  • [40] The Efficacy of Added Montelukast in Persistent Asthmatics Who Were Not Completely Controlled on Inhaled Corticosteroids and Inhaled Long-acting beta(2)-agonists
    Choi, Jeong-Hee
    Park, Hae-Sim
    Lee, Kwan-Ho
    Shim, Jae-Jeong
    Uh, Soo-Taek
    Lee, Sang-Pyo
    Lee, Yong-Chul
    Choi, Won-Il
    Kim, Joo-In
    Lee, Jae-Ho
    Lee, Myung-Goo
    Jung, Ki-Suck
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2007, 63 (04) : 337 - 345